Pure Global
NCT06414850

Animal-assisted Intervention in Adolescents Admitted to Acute Psychiatric Units.

Efficacy Study of an Animal-assisted Intervention in Adolescents Admitted to Acute Psychiatric Units: Mentaldog Multicenter Study.
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mental Health Issue
Drug/Device/Intervention
Animal Assisted Therapy (AAT)
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Location
Mataró,Lleida,Madrid, Spain
Timeline & enrollment
Phase
N/A
Start date
Feb 12, 2020
End date
Jan 07, 2022
Enrollment
178 participants
Primary outcome

Change from baseline General Self-Efficacy Scale (GSE) at 2 weeks.,Change from baseline State-Trait Anxiety Inventory Questionnaire (STAI) at 2 weeks.

Summary

The purpose of the present study was to evaluate the efficacy of AAT intervention in
 adolescents admitted to the Acute Child and Adolescent Psychiatry Unit, regardless of
 diagnosis, in terms of improving self-efficacy and reducing anxiety symptoms. To assess
 professional opinions on the effects of intervention on participants, and to determine
 participant satisfaction. These objectives were accomplished through a multicenter,
 non-randomized, open-label, two-arm controlled study of AAT for adolescents with mental
 disorders.

ICD-10 classifications
Mental disorder, not otherwise specifiedMental and behavioural disordersUnspecified mental disorderProblems related to certain psychosocial circumstancesProblems related to other psychosocial circumstances
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06414850
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06414850 through Pure Global AI's free database. This phase not specified trial is sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina and is currently Completed. The study focuses on Mental Health Issue. Target enrollment is 178 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.